We are live on
!
Find out more
CFO
Callan Family Office Portfolio holdings
AUM
$4.41B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
-3.93%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$376M
AUM Growth
-$3.77M
(-1%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
67.64%
Holding
115
New
5
Increased
27
Reduced
39
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.9M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$3.79M |
| 4 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$2.51M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$1.22M |
| 2 |
NVIDIA
NVDA
|
+$1.19M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$1.17M |
| 4 |
Eaton
ETN
|
+$1.04M |
| 5 |
iShares Emerging Markets Equity Factor ETF
EMGF
|
+$781K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 2.59% |
| 2 | Technology | 2.58% |
| 3 | Consumer Discretionary | 0.72% |
| 4 | Healthcare | 0.6% |
| 5 | Energy | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $661K | 0.18% |
5,743
| – | – |
|
52
iShares Russell 1000 ETF
IWB
$50.2B
| $650K | 0.17% |
2,769
| – | – |
|
53
Procter & Gamble
PG
$339B
| $553K | 0.15% |
3,791
-1,926
| -34% | -$294K |
|
54
iShares Silver Trust
SLV
$30.9B
| $455K | 0.12% |
+22,375
| New | +$484K |
|
55
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.41B
| $455K | 0.12% |
4,144
| – | – |
|
56
General Dynamics
GD
$106B
| $453K | 0.12% |
2,050
+230
| +13% | +$50.9K |
|
57
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $449K | 0.12% |
18,000
| – | – |
|
58
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $423K | 0.11% |
4,633
| – | – |
|
59
Caterpillar
CAT
$387B
| $423K | 0.11% |
1,550
-145
| -9% | -$39.3K |
|
60
JPMorgan Chase
JPM
$950B
| $400K | 0.11% |
2,755
-2,725
| -50% | -$408K |
|
61
Lockheed Martin
LMT
$136B
| $393K | 0.1% |
962
+120
| +14% | +$53.2K |
|
62
Merck
MRK
$318B
| $378K | 0.1% |
3,675
-3,475
| -49% | -$375K |
|
63
UnitedHealth
UNH
$370B
| $357K | 0.1% |
708
-1,098
| -61% | -$540K |
|
64
AbbVie
ABBV
$435B
| $355K | 0.09% |
2,384
-690
| -22% | -$101K |
|
65
Thermo Fisher Scientific
TMO
$220B
| $348K | 0.09% |
687
-462
| -40% | -$246K |
|
66
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $343K | 0.09% |
8,741
| – | – |
|
67
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| $342K | 0.09% |
3,387
-475
| -12% | -$50.8K |
|
68
Accenture
ACN
$108B
| $342K | 0.09% |
1,113
-1,061
| -49% | -$334K |
|
69
RTX Corp
RTX
$301B
| $306K | 0.08% |
4,245
+670
| +19% | +$57.4K |
|
70
TSMC
TSM
$2.18T
| $303K | 0.08% |
3,487
-1,354
| -28% | -$128K |
|
|
PXD
71
DELISTED
Pioneer Natural Resource Co.
PXD
| $300K | 0.08% |
1,305
| – | – |
|
72
Mastercard
MA
$493B
| $283K | 0.08% |
716
-785
| -52% | -$315K |
|
73
Oracle
ORCL
$423B
| $282K | 0.08% |
2,662
-242
| -8% | -$28K |
|
74
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $278K | 0.07% |
5,336
+1,192
| +29% | +$65.4K |
|
75
Southern Company
SO
$107B
| $270K | 0.07% |
4,171
| – | – |
|
Similar funds
FIS
CAU
EQF
SFM
EC
IC
GIBU
Callan Family Office's Q3 2023 Portfolio in Review
As of Q3 2023, Callan Family Office held 115 positions worth $376M, down 1% from $379M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Callan Family Office deployed $12M of net new capital in Q3 2023, opening 5 new positions and adding to 27 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 7,850 shares worth $1.79M.
By sector, the portfolio is most concentrated in Financials at 2.6% of assets, down from 2.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.22M trimmed.
- Callan Family Office's largest Q3 2023 buy was Arthur J. Gallagher & Co: 7,850 shares worth $1.79M.
- Callan Family Office added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $9.37M increase.
- Callan Family Office's biggest Q3 2023 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.22M.
- Callan Family Office fully exited NVIDIA in Q3 2023, selling an estimated $1.19M.
- Callan Family Office's ten largest holdings make up 68% of its $376M portfolio in Q3 2023.
- Callan Family Office opened 5 new positions and closed 28 in Q3 2023.
- Callan Family Office's portfolio value fell 1% quarter-over-quarter to $376M.
Based on Callan Family Office's 13F filing for Q3 2023, filed 14 Nov 2023.